Health insurance stocks surge an average 20.8% as Elevance Health (ELV), CVS (CVS), UnitedHealth (UNH) beat Q1 estimates and raise guidance

Health insurance providers posted strong first-quarter 2026 results, with aggregate revenues exceeding analyst consensus by 1.4% and full-year guidance in line, triggering an average share price gain of 20.8% since the latest earnings through June 5, 2026. Elevance Health (NYSE:ELV) reported revenue of $49.49 billion, up 1.5% year-over-year, beating estimates by 2.4% and raising full-year EPS guidance; shares rose 24.8% to $409.40. CVS Health (NYSE:CVS) revenue climbed 6.2% to $100.4 billion, the largest top-line beat at 6.4%, and lifted its full-year EPS outlook; the stock added 17.5% to $94.85. UnitedHealth Group (NYSE:UNH) grew revenue 2% to $111.7 billion, topped EPS and guidance, and shares gained 22.7% to $396.77. Cencora (NYSE:COR) missed revenue estimates by 3.9% on $78.36 billion in sales, and shares declined 11.6% to $270.29. Progyny (NASDAQ:PGNY) raised full-year guidance after revenue of $328.5 million beat by 0.6%; the stock surged 33.5% to $25.57.